Expertise in
1
conditions

Aija H. Knuuttila

Helsinki, FI 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
1
conditions
Helsinki, FI 

Overview

Aija Knuuttila practices in Helsinki, Finland. Ms. Knuuttila is highly rated in 1 condition, according to our data. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), PIK3CA-Related Overgrowth Spectrum, and Neuroendocrine Tumor.

Her clinical research consists of co-authoring 41 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender

Female

Locations

Helsinki, Finland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase 1 / 2 Multicenter Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of APL-101 in Subjects With Non-Small Cell Lung Cancer With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Phase 1 / 2 Multicenter Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of APL-101 in Subjects With Non-Small Cell Lung Cancer With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Enrollment Status: Recruiting
Publish Date: June 27, 2025
Intervention Type: Drug
Study Drug: APL-101
Study Phase: Phase 2
Erlotinib Treatment Beyond Progression in EGFR Mutant or Patients Who Have Responded EGFR TKI in Stage IIIB/IV NSCLC
Erlotinib Treatment Beyond Progression in EGFR Mutant or Patients Who Have Responded EGFR TKI in Stage IIIB/IV NSCLC
Enrollment Status: Completed
Publish Date: June 22, 2017
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

41 Total Publications

Association Between Obesity and Sex-Related Survival Difference in Lung Cancer.
Association Between Obesity and Sex-Related Survival Difference in Lung Cancer.
Journal: JCO clinical cancer informatics
Published: April 02, 2026

Frequently Asked Questions about Aija H. Knuuttila

Is Aija H. Knuuttila a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Aija H. Knuuttila is classified as an Advanced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Aija H. Knuuttila participate in research or clinical trials?

Yes. Aija H. Knuuttila has published 41 articles and abstracts on conditions like Lung Cancer. You can view a list of Aija H. Knuuttila's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Knuuttila's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile